ArticleCancer immunology, immunotherapy : CII2006

Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs.

Kousaku Mimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.